Insmed Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Insmed

Access the complete profile.

Insmed Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	700 Us 206 Bridgewater, NJ 08807

Note: Revenues for privately held companies are statistical evaluations.


Insmed's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Insmed's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Insmed is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Insmed Annual Revenue and Growth Rate

Insmed	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Insmed's revenues are gauged from an analysis of company filings.

Insmed's Income Statement (based on Industry Averages)

Insmed P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Insmed is developing and marketing. Insmed's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
BRINSUPRI Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; Pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; Pharmaceutical preparations for the treatment and prevention of rhinitis; Pharmaceutical preparations for the treatment and prevention of Behcet's disease; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions; Pharmaceutical preparations for the treatment and prevention of chronic rhinosinusitis; Pharmaceutical preparations for the treatment and prevention of hidradenitis suppurativa; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of metastasis	07/29/2023
NUVTEYMA Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; Pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; Pharmaceutical preparations for the treatment and prevention of rhinitis; Pharmaceutical preparations for the treatment and prevention of Behcet's disease; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions; Pharmaceutical preparations for the treatment and prevention of chronic rhinosinusitis; Pharmaceutical preparations for the treatment and prevention of hidradenitis suppurativa; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of metastasis	07/29/2023
ALGAENEX Pharmaceutical preparations, namely, protein and peptide preparations for use in human medicine; Gene therapy products, namely, gene therapy and gene editing vectors for use in human medicine	06/27/2023

See all trademarks and details in the Full Report.

Market Share of Insmed's Largest Competitors

A competitive analysis shows these companies are in the same general field as Insmed, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Insmed. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
INSMED	Bridgewater, NJ	100
EOS ENERGY STORAGE	Edison, NJ	44
NOSTRUM PHARMACEUTICALS	Somerset, NJ	26
ASPIRE PHARMACEUTICALS	Somerset, NJ	19
KASHIV BIOSCIENCES	Piscataway, NJ	17
GENSCRIPT USA	Piscataway, NJ	15

Future Competition: Insmed's Fastest Growing Competitors

These companies are in the same general field as Insmed and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)